FCSK

Chr 16AR

fucose kinase

Also known as: 1110046B12Rik, CDGF2, FUK

The protein catalyzes the phosphorylation of L-fucose to beta-L-fucose 1-phosphate, representing the first step in fucose utilization for glycoprotein and glycolipid synthesis. Mutations cause congenital disorder of glycosylation with defective fucosylation 2, which follows autosomal recessive inheritance. This gene shows low constraint to loss-of-function variants (LOEUF 1.132), suggesting some tolerance to protein disruption.

OMIMResearchSummary from RefSeq, OMIM, UniProt
ARLOEUF 1.131 OMIM phenotype
Clinical SummaryFCSK
🧬
Gene-Disease Validity (ClinGen)
congenital disorder of glycosylation with defective fucosylation 2 · ARLimited

Limited evidence — not for standalone diagnostic reporting

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.13LOEUF
pLI 0.000
Z-score 0.75
OE 0.89 (0.701.13)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
0.40Z-score
OE missense 0.96 (0.901.02)
634 obs / 662.7 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.89 (0.701.13)
00.351.4
Missense OE0.96 (0.901.02)
00.61.4
Synonymous OE0.99
01.21.6
LoF obs/exp: 48 / 53.9Missense obs/exp: 634 / 662.7Syn Z: 0.16

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

FCSK · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →